Linvoseltamab
Regeneron
['linvoseltamab', 'multiple myeloma']
our dr. hans lee presented at #asco23 a study showing linvoseltamab is efficacious and generally manageable in patients with relapsed refractory multiple myeloma, supporting continued development. 8006 #endcancer [1/2] 
MD Anderson is a global leader in cancer care, research, education and training, and prevention. Appointments available: 1-877-632-6789